There's plenty of reason to be optimistic about Synopsys' future; however, whether it could realistically make you a ...

In the most recent trading session, Synopsys (SNPS) closed at $601.55, indicating a -1.33% shift from the previous trading day.

MoneyFlows data shows how Big Money investors are again betting heavily on the stock. Institutional volumes reveal plenty. In ...

The precedent set by the SNP’s 2011 election victory would break the “logjam” towards a second independence referendum, John ...

Researchers evaluated the relative importance of phenotypic and genetic factors in predicting risk for head and neck cancer.

Bipolar disorder is a mental health condition characterized by extreme mood swings, with alternating periods of depression ...

Synopsys (SNPS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

This study reveals how machine learning models uncover new genetic variants linked to Alzheimer’s, advancing predictive ...

Researchers from The University of Osaka reveal that the intestinal flora works in combination with the mutated OTUD3 gene ...

Shares of Synopsys Inc. SNPS slid 1.33% to $601.55 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.40% to 6,388.64 and ...

A nascent hypothesis regarding pulmonary arterial hypertension (PAH) is that there is a link between thyroid dysfunction and PAH risk; much remains to be investigated to prove causality.

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. It is the largest U.S.